HealthLink pauses fee rollout The introduction of new costs for GPs to use HealthLink has been put on hold with the provider saying it will ‘undergo a period of consultation’.
HealthLink reveals new subscription fees The provider has sent out alerts about the incoming fees to many GPs and practices, with costs for larger clinics listed at $1000 a year.
‘An excellent change’: Dapagliflozin PBS access expanded The shift to increase access to more type 2 diabetes patients is in line with RACGP recommendations and clinical guidelines.
RACGP calls for GP permission to provide diabetes technology access As part of a consultation process for subsidised access to continuous glucose monitoring, the college says GPs are ‘essential’ to supporting equitable access.
Update of ‘leading handbook’ for diabetes support After four years and an evolving type 2 diabetes landscape, the RACGP has launched its refresh of the flagship clinical guideline.
In Practice: Member Engagement Survey reminder Members are encouraged to complete the 10-minute RACGP survey to ensure the issues that matter most to them are prioritised by the college.
Study: Time-restricted eating and type 2 diabetes A new study has looked at the impact of time-restricted eating on blood glucose levels, focusing on when you eat, rather than what or how much.
AI, robots, and healthcare: What does the future hold? Engineer Dr Jordan Nguyen will use his keynote address at GP24 to discuss companion robots, predictive health, and GPs’ abilities to harness AI.
Study finds 20% of UK GPs now using AI in practice The research found some GPs are using unregulated technologies, such as ChatGPT, not just for admin, but in diagnosis and treatment.
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.